business
Is Twist Bioscience Corporation (TWST) a Strong Buy After Guggenheim Lifts Price Target?
Is Twist Bioscience Corporation (TWST) a Strong Buy After Guggenheim Lifts Price Target?
Read full story on Yahoo Finance → More top storiesAlso covered by
Investing.com
Rosenblatt raises Palo Alto Networks price target to $355 on strong Q3
Investing.com
Freedom Broker raises Dave stock price target to $370 on strong results
Investing.com
Stephens raises Palo Alto Networks stock price target on strong results
Investing.com
Stifel raises MaxLinear stock price target to $105 on AI momentum
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop